Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
ECM-receptor interaction	5/88	4.376184263569622E-4	0.06000520654422431	0	0	8.569385455491028	66.27702563630513	VWF;SV2B;ITGA10;CD36;NPNT
Hematopoietic cell lineage	5/99	7.500650818028039E-4	0.06000520654422431	0	0	7.562375631409766	54.413943881570866	IL1A;ANPEP;CD38;CD36;IL6R
Protein digestion and absorption	4/103	0.0065717327673770936	0.3504924142601117	0	0	5.701875901875902	28.651799494184388	COL5A3;COL22A1;COL11A2;SLC8A2
Platelet activation	4/124	0.012426586044930504	0.4970634417972202	0	0	4.699047619047619	20.61903123994247	PLA2G4F;VWF;P2RY1;PTGS1
Arrhythmogenic right ventricular cardiomyopathy	3/77	0.018146853312934953	0.5261548685479226	0	0	5.687751581368603	22.803664123927636	CDH2;ITGA10;SLC8A2
Cytokine-cytokine receptor interaction	6/295	0.020118078325386847	0.5261548685479226	0	0	2.9437340153452687	11.498626733438549	IL1A;IL33;CXCL11;IL16;LTB;IL6R
Complement and coagulation cascades	3/85	0.0235107913493633	0.5261548685479226	0	0	5.130773222625844	19.241917046322662	VWF;VSIG4;CFB
Hypertrophic cardiomyopathy	3/90	0.027253176830472355	0.5261548685479226	0	0	4.834678405478112	17.417340791690044	TNNT2;ITGA10;SLC8A2
Dilated cardiomyopathy	3/96	0.03213845522495025	0.5261548685479226	0	0	4.521390986044383	15.543194762117535	TNNT2;ITGA10;SLC8A2
Fat digestion and absorption	2/43	0.038354176246319566	0.5261548685479226	0	0	6.806939196152525	22.19669260868441	MOGAT2;CD36
Caffeine metabolism	1/6	0.042434814389666786	0.5261548685479226	0	0	27.763636363636362	87.72715392092086	XDH
Axon guidance	4/182	0.04274480243684501	0.5261548685479226	0	0	3.1585874799357945	9.957471261334685	SEMA5A;SEMA3G;UNC5C;L1CAM
Drug metabolism	3/108	0.043182348617975985	0.5261548685479226	0	0	4.002228976697062	12.576298021922385	GSTM1;CYP2D6;XDH
Serotonergic synapse	3/113	0.04827464586316207	0.5261548685479226	0	0	3.8193423597678917	11.575849156395893	PLA2G4F;CYP2D6;PTGS1
Glutamatergic synapse	3/114	0.04932701892636775	0.5261548685479226	0	0	3.7847421889975084	11.389361452097251	PLA2G4F;SLC1A3;SHANK3
Regulation of lipolysis in adipocytes	2/55	0.059673596856796636	0.5723054896376198	0	0	5.2625564709008765	14.834439509742873	FABP4;PTGS1
Glutathione metabolism	2/57	0.06354686346484079	0.5723054896376198	0	0	5.0706786171574905	13.974676878151012	GSTM1;ANPEP
Mineral absorption	2/60	0.06951073245381138	0.5723054896376198	0	0	4.807673627974745	12.818575745414474	HEPHL1;SLC8A2
Lipid and atherosclerosis	4/215	0.07008539683589787	0.5723054896376198	0	0	2.6601218686526744	7.070712528148162	HSPA1L;CD36;POU2F2;AGER
Arachidonic acid metabolism	2/61	0.07153818620470248	0.5723054896376198	0	0	4.725948913821915	12.464803205919496	PLA2G4F;PTGS1
Inflammatory bowel disease	2/65	0.07983537880071856	0.6082695527673795	0	0	4.424994410909904	11.185450114586402	IL1A;GATA3
Cell adhesion molecules	3/148	0.09140740246346098	0.6647811088251707	0	0	2.8922964049889948	6.919613258063471	CLDN22;CDH2;L1CAM
PPAR signaling pathway	2/74	0.0995017071137836	0.6852775566145598	0	0	3.8701095461658843	8.930589236617617	FABP4;CD36
Metabolism of xenobiotics by cytochrome P450	2/76	0.10404065673452909	0.6852775566145598	0	0	3.76513132851161	8.520392518690185	GSTM1;CYP2D6
Necroptosis	3/159	0.1074014379501554	0.6852775566145598	0	0	2.6868521549372613	5.9948553808999465	IL1A;IL33;PLA2G4F
Nitrogen metabolism	1/17	0.11564058767870697	0.6852775566145598	0	0	8.671328671328672	18.706382287067274	CA7
Primary bile acid biosynthesis	1/17	0.11564058767870697	0.6852775566145598	0	0	8.671328671328672	18.706382287067274	CH25H
Cardiac muscle contraction	2/87	0.12993397395133258	0.6953648020544502	0	0	3.276056338028169	6.685542683992233	TNNT2;SLC8A2
Rheumatoid arthritis	2/93	0.14462566528162107	0.6953648020544502	0	0	3.0591239746169325	5.915141981536161	IL1A;LTB
Arginine biosynthesis	1/22	0.14705172735166475	0.6953648020544502	0	0	6.605061605061605	12.661710673988173	ARG2
Proximal tubule bicarbonate reclamation	1/23	0.15319970861687385	0.6953648020544502	0	0	6.304513668150032	11.827349118815892	AQP1
Renin-angiotensin system	1/23	0.15319970861687385	0.6953648020544502	0	0	6.304513668150032	11.827349118815892	ANPEP
AGE-RAGE signaling pathway in diabetic complications	2/100	0.16217423854157628	0.6953648020544502	0	0	2.8396090830698477	5.165487378795345	IL1A;AGER
Viral protein interaction with cytokine and cytokine receptor	2/100	0.16217423854157628	0.6953648020544502	0	0	2.8396090830698477	5.165487378795345	CXCL11;IL6R
MAPK signaling pathway	4/294	0.16266939324986748	0.6953648020544502	0	0	1.9276847290640393	3.5007437083196606	IL1A;PLA2G4F;HSPA1L;MAPK8IP2
alpha-Linolenic acid metabolism	1/25	0.16536395835057233	0.6953648020544502	0	0	5.778554778554779	10.399124313170919	PLA2G4F
Folate biosynthesis	1/26	0.17138085025327107	0.6953648020544502	0	0	5.547132867132867	9.784404634118642	TH
Maturity onset diabetes of the young	1/26	0.17138085025327107	0.6953648020544502	0	0	5.547132867132867	9.784404634118642	ONECUT1
Th17 cell differentiation	2/107	0.18008219263040173	0.6953648020544502	0	0	2.649362843729041	4.541913748765222	GATA3;IL6R
Diabetic cardiomyopathy	3/203	0.1803979524145859	0.6953648020544502	0	0	2.091063829787234	3.5811350495681906	PDK4;CD36;AGER
Linoleic acid metabolism	1/29	0.18917428872059963	0.6953648020544502	0	0	4.952047952047952	8.245588322597563	PLA2G4F
Nicotinate and nicotinamide metabolism	1/35	0.22363072641172957	0.6953648020544502	0	0	4.076923076923077	6.106248761885597	CD38
Tyrosine metabolism	1/36	0.2292303764866502	0.6953648020544502	0	0	3.96023976023976	5.833543143716861	TH
Neuroactive ligand-receptor interaction	4/341	0.23145428620318806	0.6953648020544502	0	0	1.6548537515896566	2.42166812155847	CHRNA1;VIPR1;GCGR;P2RY1
Osteoclast differentiation	2/127	0.23256468788715515	0.6953648020544502	0	0	2.2232112676056337	3.24274675345237	IL1A;OSCAR
Coronavirus disease	3/232	0.23414670853665387	0.6953648020544502	0	0	1.8235622038465111	2.6474611028586157	VWF;IL6R;CFB
Glycine, serine and threonine metabolism	1/40	0.25123072303466765	0.6953648020544502	0	0	3.5533440918056303	4.908531064512407	CBSL
Pathways of neurodegeneration	5/475	0.25781064120705427	0.6953648020544502	0	0	1.483698147864687	2.0111972203180084	IL1A;UCHL1;TUBB3;WNT3A;AGER
Estrogen signaling pathway	2/137	0.2591898360301011	0.6953648020544502	0	0	2.057485654668753	2.778005872618516	HSPA1L;FKBP5
Graft-versus-host disease	1/42	0.26199588921712913	0.6953648020544502	0	0	3.3796691113764283	4.526818251920698	IL1A
Fluid shear stress and atherosclerosis	2/139	0.26452449266876227	0.6953648020544502	0	0	2.0272437544977895	2.6958721927997082	IL1A;GSTM1
Measles	2/139	0.26452449266876227	0.6953648020544502	0	0	2.0272437544977895	2.6958721927997082	IL1A;HSPA1L
Salmonella infection	3/249	0.2668834259857385	0.6953648020544502	0	0	1.6960733437121605	2.240416758215506	ARHGEF26;TUBB3;PIK3C2G
Parkinson disease	3/249	0.2668834259857385	0.6953648020544502	0	0	1.6960733437121605	2.240416758215506	UCHL1;TH;TUBB3
Type I diabetes mellitus	1/43	0.26732069295906075	0.6953648020544502	0	0	3.299034299034299	4.352436550206619	IL1A
Porphyrin and chlorophyll metabolism	1/43	0.26732069295906075	0.6953648020544502	0	0	3.299034299034299	4.352436550206619	HEPHL1
Signaling pathways regulating pluripotency of stem cells	2/143	0.2751941441291437	0.6953648020544502	0	0	1.9693337328938167	2.5409888798569593	WNT3A;ONECUT1
Alzheimer disease	4/369	0.2754051161542066	0.6953648020544502	0	0	1.5257142857142858	1.9674270565012928	IL1A;TUBB3;WNT3A;AGER
ABC transporters	1/45	0.2778561088076697	0.6953648020544502	0	0	3.1487603305785123	4.032465879553972	ABCA12
Amino sugar and nucleotide sugar metabolism	1/48	0.2933777972902192	0.6953648020544502	0	0	2.9473292664782025	3.614292460748964	CHIT1
Adrenergic signaling in cardiomyocytes	2/150	0.2938448101515866	0.6953648020544502	0	0	1.8755234107346783	2.2969600997803203	TNNT2;SLC8A2
Cocaine addiction	1/49	0.2984777090044541	0.6953648020544502	0	0	2.885780885780886	3.4890823117534304	TH
Ether lipid metabolism	1/49	0.2984777090044541	0.6953648020544502	0	0	2.885780885780886	3.4890823117534304	PLA2G4F
Phagosome	2/152	0.29916367066495947	0.6953648020544502	0	0	1.8503286384976525	2.232910843642193	TUBB3;CD36
Arginine and proline metabolism	1/50	0.30354106685611854	0.6953648020544502	0	0	2.826744683887541	3.370153465117457	ARG2
Cholesterol metabolism	1/50	0.30354106685611854	0.6953648020544502	0	0	2.826744683887541	3.370153465117457	CD36
Cysteine and methionine metabolism	1/50	0.30354106685611854	0.6953648020544502	0	0	2.826744683887541	3.370153465117457	CBSL
Malaria	1/50	0.30354106685611854	0.6953648020544502	0	0	2.826744683887541	3.370153465117457	CD36
Oxytocin signaling pathway	2/154	0.30447637280819795	0.6953648020544502	0	0	1.8257968865826537	2.1711678906256062	PLA2G4F;CD38
Non-alcoholic fatty liver disease	2/155	0.3071301280497933	0.6953648020544502	0	0	1.81377151799687	2.1411278056265526	IL1A;IL6R
Ovarian steroidogenesis	1/51	0.30856813091166224	0.6953648020544502	0	0	2.77006993006993	3.2570831662047954	PLA2G4F
Prion disease	3/273	0.3138955088121888	0.6975455751381974	0	0	1.5434200157604412	1.788353244908172	IL1A;HSPA1L;TUBB3
Endocrine and other factor-regulated calcium reabsorption	1/53	0.31851440938712056	0.6981137739991683	0	0	2.663259817105971	3.04700243535845	SLC8A2
Legionellosis	1/57	0.33798268691525163	0.7103155444095538	0	0	2.4725274725274726	2.6821004018124146	HSPA1L
Hepatocellular carcinoma	2/168	0.34141947969466635	0.7103155444095538	0	0	1.6706261666383846	1.795327403852299	GSTM1;WNT3A
VEGF signaling pathway	1/59	0.34750868973577415	0.7103155444095538	0	0	2.387026766337111	2.5230051970501983	PLA2G4F
Influenza A	2/172	0.35187155315285273	0.7103155444095538	0	0	1.6309859154929578	1.7035469715064784	IL1A;IL33
Long-term depression	1/60	0.35222051912821756	0.7103155444095538	0	0	2.346450160009482	2.448515637833965	PLA2G4F
Glycerolipid metabolism	1/61	0.35689855753703015	0.7103155444095538	0	0	2.307226107226107	2.377143572259692	MOGAT2
Basal cell carcinoma	1/63	0.3661542224291939	0.7103155444095538	0	0	2.232573877735168	2.243068451977774	WNT3A
Cytosolic DNA-sensing pathway	1/63	0.3661542224291939	0.7103155444095538	0	0	2.232573877735168	2.243068451977774	IL33
Fc epsilon RI signaling pathway	1/68	0.38871868117706626	0.7103155444095538	0	0	2.0654420206659014	1.9516348881046108	PLA2G4F
Adipocytokine signaling pathway	1/69	0.3931349138342905	0.7103155444095538	0	0	2.034965034965035	1.8998483093920275	CD36
Amphetamine addiction	1/69	0.3931349138342905	0.7103155444095538	0	0	2.034965034965035	1.8998483093920275	TH
Renin secretion	1/69	0.3931349138342905	0.7103155444095538	0	0	2.034965034965035	1.8998483093920275	AQP1
Neutrophil extracellular trap formation	2/189	0.39560099517742525	0.7103155444095538	0	0	1.4814340588988477	1.3738066354801206	VWF;AGER
Prolactin signaling pathway	1/70	0.3975194611313408	0.7103155444095538	0	0	2.005371440154049	1.8499779892385464	TH
Inositol phosphate metabolism	1/73	0.41048524010113935	0.7103155444095538	0	0	1.9215229215229215	1.7109534213850381	PIK3C2G
Pathogenic Escherichia coli infection	2/197	0.4157219473314667	0.7103155444095538	0	0	1.4200794510653665	1.24645860327929	CLDN22;TUBB3
Pertussis	1/76	0.42317388255798444	0.7103155444095538	0	0	1.8443822843822844	1.586117333092503	IL1A
Focal adhesion	2/201	0.42565809080235006	0.7103155444095538	0	0	1.3912520348219972	1.1882946001767563	VWF;ITGA10
Human papillomavirus infection	3/331	0.427080444501011	0.7103155444095538	0	0	1.2667358588479503	1.0777171934405723	VWF;WNT3A;ITGA10
Bacterial invasion of epithelial cells	1/77	0.4273428645734816	0.7103155444095538	0	0	1.8200220831799778	1.547325674518933	ARHGEF26
Leishmaniasis	1/77	0.4273428645734816	0.7103155444095538	0	0	1.8200220831799778	1.547325674518933	IL1A
Synaptic vesicle cycle	1/78	0.4314819231616124	0.7103155444095538	0	0	1.7962946144764327	1.5098389057991934	SLC1A3
Antigen processing and presentation	1/78	0.4314819231616124	0.7103155444095538	0	0	1.7962946144764327	1.5098389057991934	HSPA1L
Peroxisome	1/82	0.44774316623341126	0.7103155444095538	0	0	1.7072433739100406	1.3718306591316785	XDH
Taste transduction	1/86	0.46354242803422685	0.7103155444095538	0	0	1.6265734265734266	1.2506029502698812	P2RY1
Regulation of actin cytoskeleton	2/218	0.46687532062159515	0.7103155444095538	0	0	1.2806468440271257	0.9754597831262328	ITGA10;SPATA13
PI3K-Akt signaling pathway	3/354	0.4703768036792898	0.7103155444095538	0	0	1.1823361823361824	0.8917430089479869	VWF;ITGA10;IL6R
Gap junction	1/88	0.47127290407065275	0.7103155444095538	0	0	1.5890201752270718	1.1954483826183349	TUBB3
Bile secretion	1/90	0.4788927442254552	0.7103155444095538	0	0	1.5531547104580812	1.1435546110035522	AQP1
Th1 and Th2 cell differentiation	1/92	0.48640352128095415	0.7103155444095538	0	0	1.5188657496349804	1.0946719243085994	GATA3
Salivary secretion	1/93	0.49011849634767923	0.7103155444095538	0	0	1.502280328367285	1.0712882523503358	CD38
GnRH signaling pathway	1/93	0.49011849634767923	0.7103155444095538	0	0	1.502280328367285	1.0712882523503358	PLA2G4F
Staphylococcus aureus infection	1/95	0.4974685783362799	0.7103155444095538	0	0	1.470168129742598	1.0265050307803938	CFB
Fc gamma R-mediated phagocytosis	1/97	0.5047134318214794	0.7103155444095538	0	0	1.4393939393939394	0.9842064377092156	PLA2G4F
Phosphatidylinositol signaling system	1/97	0.5047134318214794	0.7103155444095538	0	0	1.4393939393939394	0.9842064377092156	PIK3C2G
Choline metabolism in cancer	1/98	0.5082968662074447	0.7103155444095538	0	0	1.4244827337610844	0.9639326795067453	PLA2G4F
Glycerophospholipid metabolism	1/98	0.5082968662074447	0.7103155444095538	0	0	1.4244827337610844	0.9639326795067453	PLA2G4F
Inflammatory mediator regulation of TRP channels	1/98	0.5082968662074447	0.7103155444095538	0	0	1.4244827337610844	0.9639326795067453	PLA2G4F
Chemical carcinogenesis	2/239	0.5153134267750277	0.7103155444095538	0	0	1.1659238129197125	0.7729841318977738	GSTM1;PAQR5
Calcium signaling pathway	2/240	0.5175474101500468	0.7103155444095538	0	0	1.1609657947686116	0.764674932024783	CD38;SLC8A2
Melanogenesis	1/101	0.5188934165721454	0.7103155444095538	0	0	1.3815384615384616	0.9063676744755231	WNT3A
Amoebiasis	1/102	0.5223749571830109	0.7103155444095538	0	0	1.3677906252163679	0.8882017061384131	ARG2
Longevity regulating pathway	1/102	0.5223749571830109	0.7103155444095538	0	0	1.3677906252163679	0.8882017061384131	HSPA1L
Pancreatic secretion	1/102	0.5223749571830109	0.7103155444095538	0	0	1.3677906252163679	0.8882017061384131	CD38
Toll-like receptor signaling pathway	1/104	0.529263154909483	0.7103155444095538	0	0	1.341095797406477	0.8532983705980475	CXCL11
NF-kappa B signaling pathway	1/104	0.529263154909483	0.7103155444095538	0	0	1.341095797406477	0.8532983705980475	LTB
Parathyroid hormone synthesis, secretion and action	1/106	0.5360526923398792	0.7103155444095538	0	0	1.3154179154179155	0.820193083020888	GATA3
Glucagon signaling pathway	1/107	0.5394109027182467	0.7103155444095538	0	0	1.3029423406781897	0.8042771937006651	GCGR
Insulin resistance	1/108	0.5427449727597176	0.7103155444095538	0	0	1.2906999542513562	0.788767048367952	CD36
HIF-1 signaling pathway	1/109	0.5460550747648445	0.7103155444095538	0	0	1.2786842786842787	0.7736493036295851	IL6R
Toxoplasmosis	1/112	0.5558432773909893	0.7172171321174055	0	0	1.243936243936244	0.7305250692259913	HSPA1L
Leukocyte transendothelial migration	1/114	0.5622520103440035	0.7196825732403245	0	0	1.2217959032118324	0.703516327641536	CLDN22
AMPK signaling pathway	1/120	0.5809323851210152	0.7376919176139876	0	0	1.1598401598401598	0.6299334379990713	CD36
Purine metabolism	1/129	0.6074786743083683	0.7615192571087075	0	0	1.0777972027972027	0.5372153067837232	XDH
Natural killer cell mediated cytotoxicity	1/131	0.6131471855975835	0.7615192571087075	0	0	1.0611081226465842	0.5190413192337063	MICB
Dopaminergic synapse	1/132	0.6159508808405377	0.7615192571087075	0	0	1.0529546789088773	0.5102492625123787	TH
Vascular smooth muscle contraction	1/133	0.6187343964008248	0.7615192571087075	0	0	1.0449247721974995	0.5016466313042727	PLA2G4F
Apelin signaling pathway	1/137	0.6296695317398413	0.7690620234990428	0	0	1.013986013986014	0.4690295227439105	SLC8A2
Huntington disease	2/306	0.6495158433199992	0.7769657708796274	0	0	0.9058561897702001	0.39090235521229844	TUBB3;SLC1A3
Breast cancer	1/147	0.6556636925113501	0.7769657708796274	0	0	0.9440559440559441	0.39849289176374236	WNT3A
Phospholipase D signaling pathway	1/148	0.6581612613965017	0.7769657708796274	0	0	0.937586223300509	0.3921972860135832	PLA2G4F
Gastric cancer	1/149	0.6606408394871696	0.7769657708796274	0	0	0.9312039312039312	0.38602588349429495	WNT3A
Spliceosome	1/150	0.6631025555728509	0.7769657708796274	0	0	0.924907307457643	0.37997561491806003	HSPA1L
mTOR signaling pathway	1/154	0.672773340897571	0.7769657708796274	0	0	0.9005439005439005	0.356927688935736	WNT3A
Cushing syndrome	1/155	0.6751476451894585	0.7769657708796274	0	0	0.8946508037417128	0.3514401985522938	WNT3A
Cellular senescence	1/156	0.6775048405904793	0.7769657708796274	0	0	0.888833746898263	0.34605727018075433	IL1A
Hepatitis C	1/157	0.679845049519674	0.7769657708796274	0	0	0.8830912677066524	0.34077642057053353	CLDN22
JAK-STAT signaling pathway	1/162	0.6912955215421526	0.7790585448715274	0	0	0.8554488989271598	0.31582136062280136	IL6R
Hippo signaling pathway	1/163	0.6935363343326001	0.7790585448715274	0	0	0.8501251834585168	0.31110471181362426	WNT3A
Wnt signaling pathway	1/166	0.7001623136638775	0.7790585448715274	0	0	0.8345412163593982	0.29746645335926203	WNT3A
cGMP-PKG signaling pathway	1/167	0.7023392030902376	0.7790585448715274	0	0	0.8294717330861909	0.2930845437935516	SLC8A2
Tight junction	1/169	0.7066460067980235	0.7790585448715274	0	0	0.8195138195138195	0.28455604334995627	CLDN22
Protein processing in endoplasmic reticulum	1/171	0.7108909221952687	0.7790585448715274	0	0	0.8097902097902098	0.27632979519163003	HSPA1L
Tuberculosis	1/180	0.7292505630717936	0.7937421094658978	0	0	0.7687228972145174	0.24271495179561944	IL1A
Pathways in cancer	3/531	0.7397860616195832	0.7955352747488839	0	0	0.7788523533204385	0.234741613492658	GSTM1;WNT3A;IL6R
Alcoholism	1/186	0.7408422246098981	0.7955352747488839	0	0	0.7435645435645436	0.22304527054538517	TH
Chemokine signaling pathway	1/192	0.7519409053328604	0.7986693848143982	0	0	0.7199868194632593	0.20526647210832602	CXCL11
Kaposi sarcoma-associated herpesvirus infection	1/193	0.7537442319185882	0.7986693848143982	0	0	0.7162004662004662	0.20247143560618153	MICB
Proteoglycans in cancer	1/205	0.7743948623509975	0.8151524866852605	0	0	0.6736596736596736	0.17223684398448585	WNT3A
Rap1 signaling pathway	1/210	0.7824829845381844	0.8182828596477746	0	0	0.6573761167062603	0.16124325295717226	P2RY1
Human cytomegalovirus infection	1/225	0.8050595856609084	0.8364255435438008	0	0	0.6128871128871128	0.13289781938506767	IL6R
Ras signaling pathway	1/232	0.8147832728701266	0.8410666042530339	0	0	0.5941028668301396	0.12169194616864766	PLA2G4F
Endocytosis	1/252	0.8399903322135525	0.8615285458600537	0	0	0.5462067812665422	0.09523928887253706	HSPA1L
MicroRNAs in cancer	1/310	0.8953997762703042	0.9125093261353419	0	0	0.442369927806821	0.048875233971560704	WNT3A
Amyotrophic lateral sclerosis	1/364	0.929666660933292	0.9414345933501691	0	0	0.3755225490762681	0.027386553900084234	TUBB3
Olfactory transduction	1/440	0.9598430174944406	0.9658797660321414	0	0	0.30930117718272615	0.01267687308936331	SLC8A2
Herpes simplex virus 1 infection	1/498	0.973855850322384	0.973855850322384	0	0	0.27238958224873716	0.007216140429627294	POU2F2
